Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 40Thoracic 1Sarcoma 1Other solid neoplasm 1Head & Neck 1Genitourinary 1Endocrine 1Dermatologic 1CNS 1

Conditions

Prostatic Neoplasms 179Urinary Bladder Neoplasms 31Carcinoma, Renal Cell 19Kidney Neoplasms 18Breast Neoplasms 13Wilms Tumor 11Neoplasms 10Neoplasm Metastasis 10Lung Neoplasms 9Testicular Neoplasms 8Testicular Germ Cell Tumor 6Melanoma 6Carcinoma, Non-Small-Cell Lung 6Non-Muscle Invasive Bladder Neoplasms 5Lymphoma, Large B-Cell, Diffuse 5Endometrial Neoplasms 5Dendritic Cell Sarcoma, Interdigitating 5Burkitt Lymphoma 5Vaginal Neoplasms 4Uterine Cervical Neoplasms 4Urethral Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Seminoma 4Sarcoma 4Recurrence 4Rectal Neoplasms 4Radiation Injuries 4Multiple Myeloma 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4

Interventions

pembrolizumab 23Nivolumab 19atezolizumab 9Specimen Handling 8Ipilimumab 8Cyclophosphamide 8Magnetic Resonance Spectroscopy 6fludarabine 5cabozantinib 5Sorafenib 5sargramostim 4Trastuzumab 4Sunitinib 4Bevacizumab 4lenvatinib 3durvalumab 3avelumab 3X-Rays 3Paclitaxel 3Fluorodeoxyglucose F18 3Docetaxel 3Albumin-Bound Paclitaxel 3ulixertinib 2spartalizumab 2relatlimab 2regorafenib 2palbociclib 2epacadostat 2enzalutamide 2cemiplimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Radiotherapy × Genitourinary × Clear all
NCT02439008 2026-03-13

Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

Centre Oscar Lambret

Phase NA Terminated
28 enrolled
DermatologicGastrointestinalGenitourinary

Carcinoma, Hepatocellular, Kidney Neoplasms, Melanoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡